journal article·2021-11-08

ATP-Responsive Multifunctional Supramolecular Polymer as a Nonviral Vector for Boosting Cholesterol Removal from Lipid-Laden Macrophages

Cuiping Jiang, Yuan Wang, Peiyi Liang, Yao Chen, Ziming Zhuang, Lu Zhang, Yankui Yi, Li Liu, Qiang Liu

Publisher page

Abstract

Specific delivery of NCEH1 plasmid is a promising approach to boost the cholesterol removal from lipid-laden macrophages for antiatherosclerosis. Polyethylenimine (PEI) is one of the most efficient gene carriers among nonviral vectors. However, the high transfection activity of PEI is always accompanied by profound cytotoxicity. To tackle the paradox between transfection efficiency and safety, we constructed a novel ATP-responsive multifunctional supramolecular polymer by cross-linking functionalized low-molecular-weight PEI via a boronic ester bond for NCEH1 plasmid delivery. The supramolecular polymer could condense NCEH1 plasmids to form stable nanosized polyplexes when the w/w ratios of the polymer and gene were higher than 2. ATP-triggered degradation of the polymer and pDNA release were characterized by a series of studies, including 1H NMR, 31P NMR, XPS, agarose gel electrophoresis, and ethidium bromide exclusion tests. In addition, the changes in particle size and morphology were observed in the presence of ATP. Interestingly, the supramolecular polymer showed broad spectrum antioxidant activities by measuring the elimination rates of different reactive oxygen species. In addition, the supramolecular polymer displayed a high buffering capability and good cytocompatibility as demonstrated by the results of the buffering capacity, a hemolysis assay, and a cytotoxicity test. Importantly, it was revealed that the supramolecular polymer/NCEH1 plasmid polyplex formulated at a w/w ratio of 20 was most effective in enhancing cholesterol removal from lipid-laden macrophages and reducing the accumulation of lipid droplets as evidenced by transfection study, cholesterol efflux assay, and oil red O staining studies. Collectively, the ATP-responsive multifunctional supramolecular polymer holds great potential for safe and efficient gene delivery for antiatherosclerosis.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Lipid Membrane Structure and Behavior

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Provincial Key Laboratory of Chinese Medicine Pharmaceutics, School of Traditional Chinese Medicine, Southern Medical University, Guangzhou 510515, PR China

Funding

Guangzhou Science and Technology Program key projects · National Natural Science Foundation of China · Traditional Chinese medicine Research Fund of Guangdong Provincial Bureau

References (48)

Show source-provided references
1. 10.1016/j.jacc.2013.09.01910.1016/j.jacc.2013.09.019 ↗
2. 10.1016/j.vph.2009.10.00210.1016/j.vph.2009.10.002 ↗
3. 10.1016/j.cell.2011.04.00510.1016/j.cell.2011.04.005 ↗
4. 10.1016/j.jconrel.2019.07.00710.1016/j.jconrel.2019.07.007 ↗
5. 10.1016/j.jconrel.2018.05.04110.1016/j.jconrel.2018.05.041 ↗
6. 10.1016/j.biomaterials.2017.03.02410.1016/j.biomaterials.2017.03.024 ↗
7. 10.1074/jbc.M80268620010.1074/jbc.M802686200 ↗
8. 10.1161/CIRCRESAHA.110.22661310.1161/CIRCRESAHA.110.226613 ↗
9. 10.1172/JCI3048510.1172/JCI30485 ↗
10. 10.1021/acs.biomac.8b0050110.1021/acs.biomac.8b00501 ↗
11. 10.1021/acs.biomac.7b0043610.1021/acs.biomac.7b00436 ↗
12. 10.1002/mabi.20140046310.1002/mabi.201400463 ↗
13. 10.1038/sj.gt.330242510.1038/sj.gt.3302425 ↗
14. 10.1007/s13233-015-3047-810.1007/s13233-015-3047-8 ↗
15. 10.1080/17425247.2019.160468110.1080/17425247.2019.1604681 ↗
16. 10.1002/anie.20140026810.1002/anie.201400268 ↗
17. 10.1016/j.biomaterials.2015.01.05310.1016/j.biomaterials.2015.01.053 ↗
18. 10.1021/acs.biomac.8b0092210.1021/acs.biomac.8b00922 ↗
19. 10.1021/la302767b10.1021/la302767b ↗
20. 10.1002/advs.20170059110.1002/advs.201700591 ↗
21. 10.1021/acsmacrolett.7b0064910.1021/acsmacrolett.7b00649 ↗
22. 10.1021/jacs.6b0266410.1021/jacs.6b02664 ↗
23. 10.1021/acs.biomac.8b0139510.1021/acs.biomac.8b01395 ↗
24. 10.1016/j.colsurfb.2020.11098810.1016/j.colsurfb.2020.110988 ↗
25. 10.1016/j.atherosclerosis.2015.03.01210.1016/j.atherosclerosis.2015.03.012 ↗
26. 10.1039/C7OB02835K10.1039/C7OB02835K ↗
27. 10.1002/advs.20180078110.1002/advs.201800781 ↗
28. 10.1016/j.jff.2017.03.06010.1016/j.jff.2017.03.060 ↗
29. 10.1111/bph.1363110.1111/bph.13631 ↗
30. 10.1039/D0BM02125C10.1039/D0BM02125C ↗
31. 10.1016/j.nantod.2020.10098610.1016/j.nantod.2020.100986 ↗
32. 10.1021/bm400121q10.1021/bm400121q ↗
33. 10.1021/acsami.7b1880910.1021/acsami.7b18809 ↗
34. 10.1016/j.biomaterials.2013.02.06810.1016/j.biomaterials.2013.02.068 ↗
35. 10.2174/092986732566618103109475910.2174/0929867325666181031094759 ↗
36. 10.1016/j.jinorgbio.2005.11.02110.1016/j.jinorgbio.2005.11.021 ↗
37. 10.1039/C4CC04399E10.1039/C4CC04399E ↗
38. 10.1007/s10557-017-6758-610.1007/s10557-017-6758-6 ↗
39. 10.1093/jn/nxaa01710.1093/jn/nxaa017 ↗
40. 10.1016/j.jconrel.2019.10.05410.1016/j.jconrel.2019.10.054 ↗
41. 10.1016/j.ijpharm.2017.11.01510.1016/j.ijpharm.2017.11.015 ↗
42. 10.1515/znc-2003-9-101410.1515/znc-2003-9-1014 ↗
43. 10.1007/s10856-019-6247-510.1007/s10856-019-6247-5 ↗
44. 10.1016/j.nantod.2014.04.01110.1016/j.nantod.2014.04.011 ↗
45. 10.1002/adma.20190157010.1002/adma.201901570 ↗
46. 10.1016/j.jconrel.2011.09.09310.1016/j.jconrel.2011.09.093 ↗
47. 10.1016/j.ijpharm.2008.12.01210.1016/j.ijpharm.2008.12.012 ↗
48. 10.1194/jlr.M04778710.1194/jlr.M047787 ↗